MRO
50
7
NWSA
43
-13
UNM
75
3
NTAP
53
3
DIS
58
4
ACN
56
-12
GD
64
2
RL
68
3
TGNA
43
-2
UNH
56
-3
XYL
52
3
XOM
47
3
ORLY
64
4
IVZ
45
2
EL
30
2
MOS
16
-6
GM
58
3
CMA
58
3
LMT
49
4
NOV
42
2
MRO
50
7
NWSA
43
-13
UNM
75
3
NTAP
53
3
DIS
58
4
ACN
56
-12
GD
64
2
RL
68
3
TGNA
43
-2
UNH
56
-3
XYL
52
3
XOM
47
3
ORLY
64
4
IVZ
45
2
EL
30
2
MOS
16
-6
GM
58
3
CMA
58
3
LMT
49
4
NOV
42
2
Financhill
Back

Cytokinetics Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

CYTK
Cytokinetics

Last Price:
56.17
Seasonality Move:
-5.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $56.75. The Score for CYTK is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Buy
57
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
6.68B
Price in USD:
56.75
Volume:
809.37K
Beta:
1.45

Technical Analysis

SMA50:
56.22
SMA100:
56.37
SMA200:
62.47
52-Wk Change:
65.79%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 56.75 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-27 56.73 55.85 57.22 55.32
Aug-28 55.43 55.53 55.92 55.02
Aug-29 55.99 57.39 58.68 55.21
Aug-30 57.94 57.03 57.98 56.28
Sep-3 56.72 54.51 57.80 54.22
Sep-4 54.29 54.89 55.05 53.16
Sep-5 55.50 55.98 56.87 54.68
Sep-6 56.19 54.11 56.36 53.21
Sep-9 54.31 55.83 56.26 54.17
Sep-10 56.03 54.15 56.19 53.80
Sep-11 53.69 53.77 54.06 52.85
Sep-12 53.78 54.03 55.41 53.51
Sep-13 54.34 55.88 56.20 54.08
Sep-16 56.46 56.75 57.03 55.44

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.